Jonathan T Sockolosky

5PUBLICATIONS
40CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2025
Engineered IL-18 variants with half-life extension and improved stability for cancer immunotherapy.

Travis W Bainbridge, Lifen Wang, Marina Moskalenko

|Jan 20, 2024
i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists.

Matthew G Romei, Brandon Leonard, Zachary B Katz

|Dec 22, 2021
A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia.

Qian Zhang, Morgan E Hresko, Lora K Picton

|Jul 02, 2019
Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα.

Janet Sim, Jonathan T Sockolosky, Emma Sangalang

|Mar 03, 2018
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes.

Jonathan T Sockolosky, Eleonora Trotta, Giulia Parisi

Pageof 1

Frequent Collaborators

2 joint publications

Lora Picton

2 joint publications

Leon Su

2 joint publications

K Christopher Garcia

1 joint publications

Giulia Parisi